Supply Chain

Numerous cancer physicians who promote medications on Twitter and receive payments from drugmakers rarely acknowledge the conflict of interest, according to a study published in The Lancet Haematology.

  The U.S. Department of Homeland Security issued a warning Sept. 7 notifying health facilities of potential security flaws in several versions of the MedFusion 4000 Wireless Syringe Infusion Pump manufactured by Plymouth, Mass.-based Smiths Medical.

Cleveland Clinic pharmacists and physicians developed a strategy to limit the financial impact of rising drug prices for two common heart medications, saving the hospital an estimated $8.5 million over the span of two years, according to a case study…

More than 8,000 complaints have been made to the Florida attorney general's office over price spikes for items like food, gas and ice following Hurricane Irma. While most Americans scorn companies for raising prices after a natural disaster, some economists…

Alexion Pharmaceuticals plans to lay off 20 percent of its global workforce as part of its corporate strategy advancement plan, which the company released Tuesday.

Medtronic recalled its infusion sets — or disposable devices used to connect insulin pumps to the body — over malfunction issues, reports Bloomberg.

Teva Pharmaceuticals on Monday named Lundbeck's Kare Schultz its new CEO, reports Reuters.

Lupin Pharmaceuticals earned Food and Drug Administration approval for its generic doxycycline hyclate tablets, reports Business Standard.

Here are seven drugmakers that made headlines in the past week.

Meridian Medical Technologies, a Pfizer subsidiary that manufacturers EpiPen's for Mylan, is in hot water for failing to adequately investigate complaints about the auto-injectors' efficacy, according to The Washington Post.